vs
Getty图片控股（GETY）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Getty图片控股的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$282.3M vs $207.3M），Getty图片控股净利率更高（-32.2% vs -62.0%，领先29.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 14.1%），Getty图片控股自由现金流更多（$7.7M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 12.7%）
盖蒂图片控股是全球知名的视觉素材服务商，面向创意从业者、媒体机构与企业客户，提供正版商用图库、编辑类摄影、视频及音乐素材，旗下素材库规模超过4.77亿件，是全球视觉内容行业的龙头供应商之一。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GETY vs RARE — 直观对比
营收规模更大
GETY
是对方的1.4倍
$207.3M
营收增速更快
RARE
高出11.8%
14.1%
净利率更高
GETY
高出29.8%
-62.0%
自由现金流更多
GETY
多$108.4M
$-100.8M
两年增速更快
RARE
近两年复合增速
12.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $282.3M | $207.3M |
| 净利润 | $-90.9M | $-128.6M |
| 毛利率 | 74.8% | — |
| 营业利润率 | -8.5% | -54.7% |
| 净利率 | -32.2% | -62.0% |
| 营收同比 | 14.1% | 25.9% |
| 净利润同比 | -467.6% | 3.5% |
| 每股收益（稀释后） | $-0.22 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GETYRARE
| Q4 25 | $282.3M | $207.3M | ||
| Q3 25 | $240.0M | $159.9M | ||
| Q2 25 | $234.9M | $166.5M | ||
| Q1 25 | $224.1M | $139.3M | ||
| Q4 24 | $247.3M | $164.6M | ||
| Q3 24 | $240.5M | $139.5M | ||
| Q2 24 | $229.1M | $147.0M | ||
| Q1 24 | $222.3M | $108.8M |
净利润GETYRARE
| Q4 25 | $-90.9M | $-128.6M | ||
| Q3 25 | $21.6M | $-180.4M | ||
| Q2 25 | $-34.4M | $-115.0M | ||
| Q1 25 | $-102.6M | $-151.1M | ||
| Q4 24 | $24.7M | $-133.2M | ||
| Q3 24 | $-2.5M | $-133.5M | ||
| Q2 24 | $3.7M | $-131.6M | ||
| Q1 24 | $13.6M | $-170.7M |
毛利率GETYRARE
| Q4 25 | 74.8% | — | ||
| Q3 25 | 73.2% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 73.1% | — | ||
| Q4 24 | 73.5% | — | ||
| Q3 24 | 73.4% | — | ||
| Q2 24 | 72.5% | — | ||
| Q1 24 | 72.9% | — |
营业利润率GETYRARE
| Q4 25 | -8.5% | -54.7% | ||
| Q3 25 | 18.8% | -106.9% | ||
| Q2 25 | 15.1% | -64.8% | ||
| Q1 25 | 12.2% | -102.6% | ||
| Q4 24 | 14.5% | -74.3% | ||
| Q3 24 | 23.9% | -94.6% | ||
| Q2 24 | 20.3% | -79.1% | ||
| Q1 24 | 18.5% | -151.9% |
净利率GETYRARE
| Q4 25 | -32.2% | -62.0% | ||
| Q3 25 | 9.0% | -112.8% | ||
| Q2 25 | -14.6% | -69.0% | ||
| Q1 25 | -45.8% | -108.5% | ||
| Q4 24 | 10.0% | -80.9% | ||
| Q3 24 | -1.1% | -95.7% | ||
| Q2 24 | 1.6% | -89.5% | ||
| Q1 24 | 6.1% | -156.8% |
每股收益（稀释后）GETYRARE
| Q4 25 | $-0.22 | $-1.28 | ||
| Q3 25 | $0.05 | $-1.81 | ||
| Q2 25 | $-0.08 | $-1.17 | ||
| Q1 25 | $-0.25 | $-1.57 | ||
| Q4 24 | $0.07 | $-1.34 | ||
| Q3 24 | $-0.01 | $-1.40 | ||
| Q2 24 | $0.01 | $-1.52 | ||
| Q1 24 | $0.03 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.2M | $421.0M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $552.5M | $-80.0M |
| 总资产 | $3.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 2.30× | — |
8季度趋势，按日历期对齐
现金及短期投资GETYRARE
| Q4 25 | $90.2M | $421.0M | ||
| Q3 25 | $109.5M | $202.5M | ||
| Q2 25 | $110.3M | $176.3M | ||
| Q1 25 | $114.6M | $127.1M | ||
| Q4 24 | $121.2M | $174.0M | ||
| Q3 24 | $109.9M | $150.6M | ||
| Q2 24 | $121.7M | $480.7M | ||
| Q1 24 | $134.2M | $112.3M |
总债务GETYRARE
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
股东权益GETYRARE
| Q4 25 | $552.5M | $-80.0M | ||
| Q3 25 | $634.6M | $9.2M | ||
| Q2 25 | $611.2M | $151.3M | ||
| Q1 25 | $593.0M | $144.2M | ||
| Q4 24 | $670.2M | $255.0M | ||
| Q3 24 | $683.4M | $346.8M | ||
| Q2 24 | $654.0M | $432.4M | ||
| Q1 24 | $640.8M | $140.3M |
总资产GETYRARE
| Q4 25 | $3.2B | $1.5B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | $1.3B | ||
| Q1 25 | $2.6B | $1.3B | ||
| Q4 24 | $2.6B | $1.5B | ||
| Q3 24 | $2.6B | $1.5B | ||
| Q2 24 | $2.6B | $1.6B | ||
| Q1 24 | $2.6B | $1.3B |
负债/权益比GETYRARE
| Q4 25 | 2.30× | — | ||
| Q3 25 | 2.11× | — | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 2.21× | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 2.06× | — | ||
| Q1 24 | 2.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $7.7M | $-100.8M |
| 自由现金流率自由现金流/营收 | 2.7% | -48.6% |
| 资本支出强度资本支出/营收 | 4.6% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.7M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流GETYRARE
| Q4 25 | $20.6M | $-99.8M | ||
| Q3 25 | $22.6M | $-91.4M | ||
| Q2 25 | $6.5M | $-108.3M | ||
| Q1 25 | $15.4M | $-166.5M | ||
| Q4 24 | $39.7M | $-79.3M | ||
| Q3 24 | $10.7M | $-67.0M | ||
| Q2 24 | $46.4M | $-77.0M | ||
| Q1 24 | $21.5M | $-190.7M |
自由现金流GETYRARE
| Q4 25 | $7.7M | $-100.8M | ||
| Q3 25 | $7.9M | $-92.7M | ||
| Q2 25 | $-9.6M | $-110.7M | ||
| Q1 25 | $-322.0K | $-167.8M | ||
| Q4 24 | $24.6M | $-79.5M | ||
| Q3 24 | $-1.8M | $-68.6M | ||
| Q2 24 | $31.1M | $-79.0M | ||
| Q1 24 | $7.1M | $-193.9M |
自由现金流率GETYRARE
| Q4 25 | 2.7% | -48.6% | ||
| Q3 25 | 3.3% | -58.0% | ||
| Q2 25 | -4.1% | -66.5% | ||
| Q1 25 | -0.1% | -120.5% | ||
| Q4 24 | 9.9% | -48.3% | ||
| Q3 24 | -0.8% | -49.2% | ||
| Q2 24 | 13.6% | -53.7% | ||
| Q1 24 | 3.2% | -178.2% |
资本支出强度GETYRARE
| Q4 25 | 4.6% | 0.5% | ||
| Q3 25 | 6.1% | 0.8% | ||
| Q2 25 | 6.9% | 1.5% | ||
| Q1 25 | 7.0% | 1.0% | ||
| Q4 24 | 6.1% | 0.1% | ||
| Q3 24 | 5.2% | 1.2% | ||
| Q2 24 | 6.7% | 1.4% | ||
| Q1 24 | 6.5% | 3.0% |
现金转化率GETYRARE
| Q4 25 | — | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.59× | — | ||
| Q1 24 | 1.58× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
